Intervention Review

Therapeutic monitoring of antiepileptic drugs for epilepsy

  1. Torbjörn Tomson1,*,
  2. Marja-Liisa Dahl2,
  3. Elin Kimland3

Editorial Group: Cochrane Epilepsy Group

Published Online: 18 APR 2007

Assessed as up-to-date: 5 FEB 2010

DOI: 10.1002/14651858.CD002216.pub2

How to Cite

Tomson T, Dahl ML, Kimland E. Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD002216. DOI: 10.1002/14651858.CD002216.pub2.

Author Information

  1. 1

    Karolinska University Hospital, Department of Neurology, Stockholm, Sweden

  2. 2

    Akademiska sjukhuset, Department of Clinical Pharmacology, 75185 Uppsala, Sweden

  3. 3

    Karolinska University Hospital - Solna, Adverse Drug Monitoring Centre, Clinical Pharmacology L7:05, Stockholm, Sweden

*Torbjörn Tomson, Department of Neurology, Karolinska University Hospital, Stockholm, S-171 76, Sweden.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 APR 2007


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.